Novamass Analytical Ltd is leading Scandinavian ADME contract research company from Oulu, Finland (www.novamass.net).
We perform contract analytical and ADME studies for drug discovery and development companies. Our services can be tailored to meet your needs from discovery phase to candidate drug characterisation. Our mission is to assist the drug developers to understand the characteristics of their molecules by offering comprehensive ADME services for every stage of their drug development obtainable from a single source.
Company's core competencies are studies on in vitro drug metabolism, CYP related drug-drug interactions and permeation. Besides ADME studies, Novamass also provides tailor-made problem solving based on LC/MS and NMR techniques (custom analysis) for biopharmaceutical and chemical industry, and natural product analysis.
Our current ADME studies include:
1) Basic property characterization (solubility, pKa, lipophilicity, degradation)
2) Metabolism studies (metabolic stability and metabolite identification)
3) Permeation studies (incl. Caco-2, MDCK, skin tissue)
4) Drug-drug interaction studies (CYP inhibition, induction, enzyme identification)
5) In vivo ADME studies